According to AlphaMoat, in 2026-08 Insilico Medicine (insilico.com) received 48,955 monthly visits (-23.1% MoM) — ranked #5,212 of 17,407 AI websites with traffic data, and #630 of 3,173 in Industry Services; its largest market is United States (34.9% of visits).
Monthly Visits · 2026-08
49.0K-23.1%
Overall Rank (17,407)
#5,212
Industry Services Rank (3,173)
#630
Top Market
United States34.9%
What is Insilico Medicine
Product Overview
Headquartered in Shanghai, Insilico Medicine develops candidate drugs for anti-aging and cancer treatment.
Key Features3 items
01Generative AI combined with a biology platform
02Accelerate target discovery
03Accelerate compound design
12-Month Traffic Trend
Hover for monthly values
Latest 49.0KMoM-23.1%
2026-06
62.0K
—
2026-07
63.7K
+2.7%
2026-08
49.0K
-23.1%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
17,09834.9%
UK
4,8579.9%
India
4,3999.0%
Germany
4,0138.2%
Belgium
3,0636.3%
Popular in Industry Services
Click for details, or "+ Compare" to compare with Insilico Medicine
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.